US Patent Issued to The University of North Carolina at Chapel Hill on March 17 for "Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor" (North Carolina Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,312, issued on March 17, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.).

"Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor" was invented by Stergios Moschos (Chapel Hill, N.C.) and Maureen Su (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of treating melanoma, such as, e.g., stage III/IV cutaneous or mucosal melanoma, in a subject in need thereof, comprising administering a therapeutically effective amount of denosumab to the subject and optionally co-administering a therapeutically effective amount of a PD-1 inhibitor to the...